After researching the safety and effectiveness of CBD oil for treating epilepsy, the FDA approved the use of CBD (Epidiolex) as a therapy for two rare conditions characterized by epileptic seizures in 2018.
In the U.S., a doctor can prescribe Epidiolex to treat:
- Lennox-Gastaut syndrome (LGS), a condition that appears between the ages of 3 and 5 years and involves different kinds of seizures
- Dravet syndrome (DS), a rare genetic condition that appears in the first year of life and involves frequent, fever-related seizures
The types of seizures that characterize LGS or DS are difficult to control with other types of medication.